UPMC Sells Ownership of Series A Common Stock in Evolent Health, Inc.

UPMC sold nearly one quarter of its 22.5% ownership of Series A Common Stock in Evolent Health, Inc. in an underwritten secondary public offering that resulted in approximately $146.5 million in aggregate proceeds to the selling stockholders, including approximately $52.6 million to UPMC. Our firm represented UPMC in the transaction.